Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fei Re Qing Granules for Elderly Community-Acquired Pneumonia
NCT06747325Not yet recruiting
- Sponsor
- Henan University of Chinese Medicine
- Start
- Jan 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of Fei Re Qing Granules in community acquired pneumonia (CAP), sponsored by Henan University of Chinese Medicine. Primary endpoint: Time to Clinical Stability at 2 weeks. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
Fei Re Qing Granules
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06747325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06747325.